Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.
Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, O'Dwyer PJ.
Scher RM, et al. Among authors: alexander r.
Invest New Drugs. 1996;13(4):347-54. doi: 10.1007/BF00873143.
Invest New Drugs. 1996.
PMID: 8824355
Clinical Trial.